0000950170-24-061276.txt : 20240516 0000950170-24-061276.hdr.sgml : 20240516 20240516185739 ACCESSION NUMBER: 0000950170-24-061276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240515 FILED AS OF DATE: 20240516 DATE AS OF CHANGE: 20240516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patterson Joshua F. CENTRAL INDEX KEY: 0001805702 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41925 FILM NUMBER: 24957282 MAIL ADDRESS: STREET 1: C/O GAMIDA CELL LTD. STREET 2: 116 HUNTINGTON AVENUE CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CG Oncology, Inc. CENTRAL INDEX KEY: 0001991792 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 371611499 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 SPECTRUM CENTER DRIVE STREET 2: SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 419-6203 MAIL ADDRESS: STREET 1: 400 SPECTRUM CENTER DRIVE STREET 2: SUITE 2040 CITY: IRVINE STATE: CA ZIP: 92618 4 1 ownership.xml 4 X0508 4 2024-05-15 0001991792 CG Oncology, Inc. CGON 0001805702 Patterson Joshua F. C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618 false true false false See Remarks false Stock Option (Right to Buy) 28.01 2024-05-15 4 A false 100000 0 A 2034-05-14 Common Stock 100000 100000 D The stock option vests as to 25% of the underlying shares on June 1, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter. General Counsel and Chief Compliance Officer /s/ Joshua F. Patterson 2024-05-16